Filing Details

Accession Number:
0000899243-18-029386
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-19 20:12:27
Reporting Period:
2018-11-19
Accepted Time:
2018-11-19 20:12:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631650 Aimmune Therapeutics Inc. AIMT Pharmaceutical Preparations (2834) 452748244
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650322 Alexander Donald Jayson Dallas Aimmune Therapeutics, Inc.
8000 Marina Boulevard, Suite 300
Brisbane CA 94005-1884
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Acquisiton 2018-11-19 3,600 $27.56 63,600 No 4 P Direct
Common Stock, $0.0001 Par Value Acquisiton 2018-11-19 50 $27.56 63,650 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct